Protagonist Therapeutics Statistics
Total Valuation
PTGX has a market cap or net worth of $3.63 billion. The enterprise value is $2.97 billion.
| Market Cap | 3.63B |
| Enterprise Value | 2.97B |
Important Dates
The next estimated earnings date is Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PTGX has 62.21 million shares outstanding. The number of shares has increased by 4.64% in one year.
| Current Share Class | 62.21M |
| Shares Outstanding | 62.21M |
| Shares Change (YoY) | +4.64% |
| Shares Change (QoQ) | +0.87% |
| Owned by Insiders (%) | 1.03% |
| Owned by Institutions (%) | 86.16% |
| Float | 43.16M |
Valuation Ratios
The trailing PE ratio is 72.57 and the forward PE ratio is 262.55.
| PE Ratio | 72.57 |
| Forward PE | 262.55 |
| PS Ratio | 17.48 |
| Forward PS | 35.39 |
| PB Ratio | 5.43 |
| P/TBV Ratio | 5.44 |
| P/FCF Ratio | 97.90 |
| P/OCF Ratio | 91.85 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 119.44, with an EV/FCF ratio of 80.06.
| EV / Earnings | 57.08 |
| EV / Sales | 14.20 |
| EV / EBITDA | 119.44 |
| EV / EBIT | 123.88 |
| EV / FCF | 80.06 |
Financial Position
The company has a current ratio of 16.97, with a Debt / Equity ratio of 0.02.
| Current Ratio | 16.97 |
| Quick Ratio | 16.85 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.41 |
| Debt / FCF | 0.30 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 8.61% and return on invested capital (ROIC) is 2.43%.
| Return on Equity (ROE) | 8.61% |
| Return on Assets (ROA) | 2.25% |
| Return on Invested Capital (ROIC) | 2.43% |
| Return on Capital Employed (ROCE) | 3.51% |
| Revenue Per Employee | $1.66M |
| Profits Per Employee | $413,000 |
| Employee Count | 126 |
| Asset Turnover | 0.31 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PTGX has paid $1.74 million in taxes.
| Income Tax | 1.74M |
| Effective Tax Rate | 3.24% |
Stock Price Statistics
The stock price has increased by +24.16% in the last 52 weeks. The beta is 2.22, so PTGX's price volatility has been higher than the market average.
| Beta (5Y) | 2.22 |
| 52-Week Price Change | +24.16% |
| 50-Day Moving Average | 55.69 |
| 200-Day Moving Average | 47.28 |
| Relative Strength Index (RSI) | 53.07 |
| Average Volume (20 Days) | 923,576 |
Short Selling Information
The latest short interest is 6.85 million, so 11.01% of the outstanding shares have been sold short.
| Short Interest | 6.85M |
| Short Previous Month | 6.31M |
| Short % of Shares Out | 11.01% |
| Short % of Float | 15.86% |
| Short Ratio (days to cover) | 10.47 |
Income Statement
In the last 12 months, PTGX had revenue of $209.18 million and earned $52.04 million in profits. Earnings per share was $0.80.
| Revenue | 209.18M |
| Gross Profit | 209.18M |
| Operating Income | 23.98M |
| Pretax Income | 172.60M |
| Net Income | 52.04M |
| EBITDA | 24.87M |
| EBIT | 23.98M |
| Earnings Per Share (EPS) | $0.80 |
Balance Sheet
The company has $570.47 million in cash and $11.28 million in debt, giving a net cash position of $661.68 million or $10.64 per share.
| Cash & Cash Equivalents | 570.47M |
| Total Debt | 11.28M |
| Net Cash | 661.68M |
| Net Cash Per Share | $10.64 |
| Equity (Book Value) | 668.02M |
| Book Value Per Share | 10.76 |
| Working Capital | 567.02M |
Cash Flow
In the last 12 months, operating cash flow was $39.54 million and capital expenditures -$2.44 million, giving a free cash flow of $37.10 million.
| Operating Cash Flow | 39.54M |
| Capital Expenditures | -2.44M |
| Free Cash Flow | 37.10M |
| FCF Per Share | $0.60 |
Margins
Gross margin is 100.00%, with operating and profit margins of 11.46% and 24.88%.
| Gross Margin | 100.00% |
| Operating Margin | 11.46% |
| Pretax Margin | 25.71% |
| Profit Margin | 24.88% |
| EBITDA Margin | 11.89% |
| EBIT Margin | 11.46% |
| FCF Margin | 17.74% |
Dividends & Yields
PTGX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.64% |
| Shareholder Yield | -4.64% |
| Earnings Yield | 1.43% |
| FCF Yield | 1.02% |
Analyst Forecast
The average price target for PTGX is $70.44, which is 20.66% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $70.44 |
| Price Target Difference | 20.66% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 1.67% |
| EPS Growth Forecast (5Y) | 0.40% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PTGX has an Altman Z-Score of 31.97 and a Piotroski F-Score of 4.
| Altman Z-Score | 31.97 |
| Piotroski F-Score | 4 |